ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Safety Pharmacology Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-16F11941
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Safety Pharmacology Market Research Report 2022
BUY CHAPTERS

Global Safety Pharmacology Market Research Report 2024

Code: QYRE-Auto-16F11941
Report
April 2024
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Charles River
Pharmaron
Reaction Biology
Eurofins Discovery
Tergus Pharma
QIMA Life Sciences
TKTsweden

Safety Pharmacology Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Safety Pharmacology Market

Safety Pharmacology Market

The global Safety Pharmacology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Safety Pharmacology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Safety Pharmacology.

Report Scope

The Safety Pharmacology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Safety Pharmacology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Safety Pharmacology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Safety Pharmacology Market Report

Report Metric Details
Report Name Safety Pharmacology Market
CAGR 5%
Segment by Type
  • Respiratory System
  • Central Nervous System
  • Cardiovascular System
  • Medical Device Safety Evaluation
  • Natural Product Safety Evaluation
  • Others
Segment by Application
  • Large Animal Species
  • Small Animal Species
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, PerkinElmer, Merck, Charles River, TKTsweden, Pharmaron, Reaction Biology, Eurofins Discovery, Frontage Laboratories, Tergus Pharma, QIMA Life Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Safety Pharmacology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Safety Pharmacology Market report?

Ans: The main players in the Safety Pharmacology Market are Thermo Fisher Scientific, PerkinElmer, Merck, Charles River, TKTsweden, Pharmaron, Reaction Biology, Eurofins Discovery, Frontage Laboratories, Tergus Pharma, QIMA Life Sciences

What are the Application segmentation covered in the Safety Pharmacology Market report?

Ans: The Applications covered in the Safety Pharmacology Market report are Large Animal Species, Small Animal Species

What are the Type segmentation covered in the Safety Pharmacology Market report?

Ans: The Types covered in the Safety Pharmacology Market report are Respiratory System, Central Nervous System, Cardiovascular System, Medical Device Safety Evaluation, Natural Product Safety Evaluation, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Safety Pharmacology Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Respiratory System
1.2.3 Central Nervous System
1.2.4 Cardiovascular System
1.2.5 Medical Device Safety Evaluation
1.2.6 Natural Product Safety Evaluation
1.2.7 Others
1.3 Market by Application
1.3.1 Global Safety Pharmacology Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Large Animal Species
1.3.3 Small Animal Species
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Safety Pharmacology Market Perspective (2019-2030)
2.2 Safety Pharmacology Growth Trends by Region
2.2.1 Global Safety Pharmacology Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Safety Pharmacology Historic Market Size by Region (2019-2024)
2.2.3 Safety Pharmacology Forecasted Market Size by Region (2025-2030)
2.3 Safety Pharmacology Market Dynamics
2.3.1 Safety Pharmacology Industry Trends
2.3.2 Safety Pharmacology Market Drivers
2.3.3 Safety Pharmacology Market Challenges
2.3.4 Safety Pharmacology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Safety Pharmacology Players by Revenue
3.1.1 Global Top Safety Pharmacology Players by Revenue (2019-2024)
3.1.2 Global Safety Pharmacology Revenue Market Share by Players (2019-2024)
3.2 Global Safety Pharmacology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Safety Pharmacology Revenue
3.4 Global Safety Pharmacology Market Concentration Ratio
3.4.1 Global Safety Pharmacology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Safety Pharmacology Revenue in 2023
3.5 Safety Pharmacology Key Players Head office and Area Served
3.6 Key Players Safety Pharmacology Product Solution and Service
3.7 Date of Enter into Safety Pharmacology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Safety Pharmacology Breakdown Data by Type
4.1 Global Safety Pharmacology Historic Market Size by Type (2019-2024)
4.2 Global Safety Pharmacology Forecasted Market Size by Type (2025-2030)
5 Safety Pharmacology Breakdown Data by Application
5.1 Global Safety Pharmacology Historic Market Size by Application (2019-2024)
5.2 Global Safety Pharmacology Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Safety Pharmacology Market Size (2019-2030)
6.2 North America Safety Pharmacology Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Safety Pharmacology Market Size by Country (2019-2024)
6.4 North America Safety Pharmacology Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Safety Pharmacology Market Size (2019-2030)
7.2 Europe Safety Pharmacology Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Safety Pharmacology Market Size by Country (2019-2024)
7.4 Europe Safety Pharmacology Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Safety Pharmacology Market Size (2019-2030)
8.2 Asia-Pacific Safety Pharmacology Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Safety Pharmacology Market Size by Region (2019-2024)
8.4 Asia-Pacific Safety Pharmacology Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Safety Pharmacology Market Size (2019-2030)
9.2 Latin America Safety Pharmacology Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Safety Pharmacology Market Size by Country (2019-2024)
9.4 Latin America Safety Pharmacology Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Safety Pharmacology Market Size (2019-2030)
10.2 Middle East & Africa Safety Pharmacology Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Safety Pharmacology Market Size by Country (2019-2024)
10.4 Middle East & Africa Safety Pharmacology Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Safety Pharmacology Introduction
11.1.4 Thermo Fisher Scientific Revenue in Safety Pharmacology Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 PerkinElmer
11.2.1 PerkinElmer Company Detail
11.2.2 PerkinElmer Business Overview
11.2.3 PerkinElmer Safety Pharmacology Introduction
11.2.4 PerkinElmer Revenue in Safety Pharmacology Business (2019-2024)
11.2.5 PerkinElmer Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Safety Pharmacology Introduction
11.3.4 Merck Revenue in Safety Pharmacology Business (2019-2024)
11.3.5 Merck Recent Development
11.4 Charles River
11.4.1 Charles River Company Detail
11.4.2 Charles River Business Overview
11.4.3 Charles River Safety Pharmacology Introduction
11.4.4 Charles River Revenue in Safety Pharmacology Business (2019-2024)
11.4.5 Charles River Recent Development
11.5 TKTsweden
11.5.1 TKTsweden Company Detail
11.5.2 TKTsweden Business Overview
11.5.3 TKTsweden Safety Pharmacology Introduction
11.5.4 TKTsweden Revenue in Safety Pharmacology Business (2019-2024)
11.5.5 TKTsweden Recent Development
11.6 Pharmaron
11.6.1 Pharmaron Company Detail
11.6.2 Pharmaron Business Overview
11.6.3 Pharmaron Safety Pharmacology Introduction
11.6.4 Pharmaron Revenue in Safety Pharmacology Business (2019-2024)
11.6.5 Pharmaron Recent Development
11.7 Reaction Biology
11.7.1 Reaction Biology Company Detail
11.7.2 Reaction Biology Business Overview
11.7.3 Reaction Biology Safety Pharmacology Introduction
11.7.4 Reaction Biology Revenue in Safety Pharmacology Business (2019-2024)
11.7.5 Reaction Biology Recent Development
11.8 Eurofins Discovery
11.8.1 Eurofins Discovery Company Detail
11.8.2 Eurofins Discovery Business Overview
11.8.3 Eurofins Discovery Safety Pharmacology Introduction
11.8.4 Eurofins Discovery Revenue in Safety Pharmacology Business (2019-2024)
11.8.5 Eurofins Discovery Recent Development
11.9 Frontage Laboratories
11.9.1 Frontage Laboratories Company Detail
11.9.2 Frontage Laboratories Business Overview
11.9.3 Frontage Laboratories Safety Pharmacology Introduction
11.9.4 Frontage Laboratories Revenue in Safety Pharmacology Business (2019-2024)
11.9.5 Frontage Laboratories Recent Development
11.10 Tergus Pharma
11.10.1 Tergus Pharma Company Detail
11.10.2 Tergus Pharma Business Overview
11.10.3 Tergus Pharma Safety Pharmacology Introduction
11.10.4 Tergus Pharma Revenue in Safety Pharmacology Business (2019-2024)
11.10.5 Tergus Pharma Recent Development
11.11 QIMA Life Sciences
11.11.1 QIMA Life Sciences Company Detail
11.11.2 QIMA Life Sciences Business Overview
11.11.3 QIMA Life Sciences Safety Pharmacology Introduction
11.11.4 QIMA Life Sciences Revenue in Safety Pharmacology Business (2019-2024)
11.11.5 QIMA Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Merck
Charles River
Pharmaron
Reaction Biology
Eurofins Discovery
Tergus Pharma
QIMA Life Sciences
TKTsweden
List of Tables
    Table 1. Global Safety Pharmacology Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Respiratory System
    Table 3. Key Players of Central Nervous System
    Table 4. Key Players of Cardiovascular System
    Table 5. Key Players of Medical Device Safety Evaluation
    Table 6. Key Players of Natural Product Safety Evaluation
    Table 7. Key Players of Others
    Table 8. Global Safety Pharmacology Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Safety Pharmacology Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 10. Global Safety Pharmacology Market Size by Region (2019-2024) & (US$ Million)
    Table 11. Global Safety Pharmacology Market Share by Region (2019-2024)
    Table 12. Global Safety Pharmacology Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 13. Global Safety Pharmacology Market Share by Region (2025-2030)
    Table 14. Safety Pharmacology Market Trends
    Table 15. Safety Pharmacology Market Drivers
    Table 16. Safety Pharmacology Market Challenges
    Table 17. Safety Pharmacology Market Restraints
    Table 18. Global Safety Pharmacology Revenue by Players (2019-2024) & (US$ Million)
    Table 19. Global Safety Pharmacology Market Share by Players (2019-2024)
    Table 20. Global Top Safety Pharmacology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Safety Pharmacology as of 2023)
    Table 21. Ranking of Global Top Safety Pharmacology Companies by Revenue (US$ Million) in 2023
    Table 22. Global 5 Largest Players Market Share by Safety Pharmacology Revenue (CR5 and HHI) & (2019-2024)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Safety Pharmacology Product Solution and Service
    Table 25. Date of Enter into Safety Pharmacology Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Safety Pharmacology Market Size by Type (2019-2024) & (US$ Million)
    Table 28. Global Safety Pharmacology Revenue Market Share by Type (2019-2024)
    Table 29. Global Safety Pharmacology Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 30. Global Safety Pharmacology Revenue Market Share by Type (2025-2030)
    Table 31. Global Safety Pharmacology Market Size by Application (2019-2024) & (US$ Million)
    Table 32. Global Safety Pharmacology Revenue Market Share by Application (2019-2024)
    Table 33. Global Safety Pharmacology Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 34. Global Safety Pharmacology Revenue Market Share by Application (2025-2030)
    Table 35. North America Safety Pharmacology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Safety Pharmacology Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Safety Pharmacology Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Safety Pharmacology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 39. Europe Safety Pharmacology Market Size by Country (2019-2024) & (US$ Million)
    Table 40. Europe Safety Pharmacology Market Size by Country (2025-2030) & (US$ Million)
    Table 41. Asia-Pacific Safety Pharmacology Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 42. Asia-Pacific Safety Pharmacology Market Size by Region (2019-2024) & (US$ Million)
    Table 43. Asia-Pacific Safety Pharmacology Market Size by Region (2025-2030) & (US$ Million)
    Table 44. Latin America Safety Pharmacology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Latin America Safety Pharmacology Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Latin America Safety Pharmacology Market Size by Country (2025-2030) & (US$ Million)
    Table 47. Middle East & Africa Safety Pharmacology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 48. Middle East & Africa Safety Pharmacology Market Size by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Safety Pharmacology Market Size by Country (2025-2030) & (US$ Million)
    Table 50. Thermo Fisher Scientific Company Detail
    Table 51. Thermo Fisher Scientific Business Overview
    Table 52. Thermo Fisher Scientific Safety Pharmacology Product
    Table 53. Thermo Fisher Scientific Revenue in Safety Pharmacology Business (2019-2024) & (US$ Million)
    Table 54. Thermo Fisher Scientific Recent Development
    Table 55. PerkinElmer Company Detail
    Table 56. PerkinElmer Business Overview
    Table 57. PerkinElmer Safety Pharmacology Product
    Table 58. PerkinElmer Revenue in Safety Pharmacology Business (2019-2024) & (US$ Million)
    Table 59. PerkinElmer Recent Development
    Table 60. Merck Company Detail
    Table 61. Merck Business Overview
    Table 62. Merck Safety Pharmacology Product
    Table 63. Merck Revenue in Safety Pharmacology Business (2019-2024) & (US$ Million)
    Table 64. Merck Recent Development
    Table 65. Charles River Company Detail
    Table 66. Charles River Business Overview
    Table 67. Charles River Safety Pharmacology Product
    Table 68. Charles River Revenue in Safety Pharmacology Business (2019-2024) & (US$ Million)
    Table 69. Charles River Recent Development
    Table 70. TKTsweden Company Detail
    Table 71. TKTsweden Business Overview
    Table 72. TKTsweden Safety Pharmacology Product
    Table 73. TKTsweden Revenue in Safety Pharmacology Business (2019-2024) & (US$ Million)
    Table 74. TKTsweden Recent Development
    Table 75. Pharmaron Company Detail
    Table 76. Pharmaron Business Overview
    Table 77. Pharmaron Safety Pharmacology Product
    Table 78. Pharmaron Revenue in Safety Pharmacology Business (2019-2024) & (US$ Million)
    Table 79. Pharmaron Recent Development
    Table 80. Reaction Biology Company Detail
    Table 81. Reaction Biology Business Overview
    Table 82. Reaction Biology Safety Pharmacology Product
    Table 83. Reaction Biology Revenue in Safety Pharmacology Business (2019-2024) & (US$ Million)
    Table 84. Reaction Biology Recent Development
    Table 85. Eurofins Discovery Company Detail
    Table 86. Eurofins Discovery Business Overview
    Table 87. Eurofins Discovery Safety Pharmacology Product
    Table 88. Eurofins Discovery Revenue in Safety Pharmacology Business (2019-2024) & (US$ Million)
    Table 89. Eurofins Discovery Recent Development
    Table 90. Frontage Laboratories Company Detail
    Table 91. Frontage Laboratories Business Overview
    Table 92. Frontage Laboratories Safety Pharmacology Product
    Table 93. Frontage Laboratories Revenue in Safety Pharmacology Business (2019-2024) & (US$ Million)
    Table 94. Frontage Laboratories Recent Development
    Table 95. Tergus Pharma Company Detail
    Table 96. Tergus Pharma Business Overview
    Table 97. Tergus Pharma Safety Pharmacology Product
    Table 98. Tergus Pharma Revenue in Safety Pharmacology Business (2019-2024) & (US$ Million)
    Table 99. Tergus Pharma Recent Development
    Table 100. QIMA Life Sciences Company Detail
    Table 101. QIMA Life Sciences Business Overview
    Table 102. QIMA Life Sciences Safety Pharmacology Product
    Table 103. QIMA Life Sciences Revenue in Safety Pharmacology Business (2019-2024) & (US$ Million)
    Table 104. QIMA Life Sciences Recent Development
    Table 105. Research Programs/Design for This Report
    Table 106. Key Data Information from Secondary Sources
    Table 107. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Safety Pharmacology Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Safety Pharmacology Market Share by Type: 2023 VS 2030
    Figure 3. Respiratory System Features
    Figure 4. Central Nervous System Features
    Figure 5. Cardiovascular System Features
    Figure 6. Medical Device Safety Evaluation Features
    Figure 7. Natural Product Safety Evaluation Features
    Figure 8. Others Features
    Figure 9. Global Safety Pharmacology Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 10. Global Safety Pharmacology Market Share by Application: 2023 VS 2030
    Figure 11. Large Animal Species Case Studies
    Figure 12. Small Animal Species Case Studies
    Figure 13. Safety Pharmacology Report Years Considered
    Figure 14. Global Safety Pharmacology Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Safety Pharmacology Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Safety Pharmacology Market Share by Region: 2023 VS 2030
    Figure 17. Global Safety Pharmacology Market Share by Players in 2023
    Figure 18. Global Top Safety Pharmacology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Safety Pharmacology as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Safety Pharmacology Revenue in 2023
    Figure 20. North America Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Safety Pharmacology Market Share by Country (2019-2030)
    Figure 22. United States Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Safety Pharmacology Market Share by Country (2019-2030)
    Figure 26. Germany Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. France Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. U.K. Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Italy Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Russia Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Nordic Countries Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Asia-Pacific Safety Pharmacology Market Share by Region (2019-2030)
    Figure 34. China Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Japan Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. South Korea Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Southeast Asia Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. India Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Australia Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Latin America Safety Pharmacology Market Share by Country (2019-2030)
    Figure 42. Mexico Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Brazil Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East & Africa Safety Pharmacology Market Share by Country (2019-2030)
    Figure 46. Turkey Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Saudi Arabia Safety Pharmacology Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Safety Pharmacology Business (2019-2024)
    Figure 49. PerkinElmer Revenue Growth Rate in Safety Pharmacology Business (2019-2024)
    Figure 50. Merck Revenue Growth Rate in Safety Pharmacology Business (2019-2024)
    Figure 51. Charles River Revenue Growth Rate in Safety Pharmacology Business (2019-2024)
    Figure 52. TKTsweden Revenue Growth Rate in Safety Pharmacology Business (2019-2024)
    Figure 53. Pharmaron Revenue Growth Rate in Safety Pharmacology Business (2019-2024)
    Figure 54. Reaction Biology Revenue Growth Rate in Safety Pharmacology Business (2019-2024)
    Figure 55. Eurofins Discovery Revenue Growth Rate in Safety Pharmacology Business (2019-2024)
    Figure 56. Frontage Laboratories Revenue Growth Rate in Safety Pharmacology Business (2019-2024)
    Figure 57. Tergus Pharma Revenue Growth Rate in Safety Pharmacology Business (2019-2024)
    Figure 58. QIMA Life Sciences Revenue Growth Rate in Safety Pharmacology Business (2019-2024)
    Figure 59. Bottom-up and Top-down Approaches for This Report
    Figure 60. Data Triangulation
    Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Platinum-based Anticancer Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-6P8206
Sun Nov 24 00:00:00 UTC 2024

Add to Cart

Ether Solvent for Pharmaceutical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-22W13490
Sun Nov 24 00:00:00 UTC 2024

Add to Cart

Clinical Trial Imaging Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-0Z6112
Sun Nov 24 00:00:00 UTC 2024

Add to Cart

Smart Pills and Drugs Delivery System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-5Q14261
Fri Nov 22 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions